MARS 发表于 2025-3-25 05:12:18

Submitted on: 03 September 2021.
Revised on: 27 October 2021.
Accepted on: 22 December 2021.

___________________HIV Research & Clinical Practice

猜忌 发表于 2025-3-25 07:43:18

Submitted on: 04 March 2011.
Revised on: 27 May 2011.
Accepted on: 21 June 2011.

___________________HIV Research & Clinical Practice

先兆 发表于 2025-3-25 12:07:09

Submitted on: 15 February 2017.
Revised on: 17 April 2017.
Accepted on: 01 June 2017.

___________________HIV Research & Clinical Practice

Hyperopia 发表于 2025-3-25 18:15:00

http://reply.papertrans.cn/2/115/11451/11451-24.png

Pcos971 发表于 2025-3-25 20:02:05

http://reply.papertrans.cn/2/115/11451/11451-25.png

密码 发表于 2025-3-26 01:21:53

http://reply.papertrans.cn/2/115/11451/11451-26.png

Insensate 发表于 2025-3-26 07:14:20

http://reply.papertrans.cn/2/115/11451/11451-27.png

天真 发表于 2025-3-26 11:15:30

Submitted on: 28 March 2013.
Revised on: 26 May 2013.
Accepted on: 24 July 2013.

___________________HIV Research & Clinical Practice

繁荣地区 发表于 2025-3-26 13:52:14

Submitted on: 07 March 2019.
Revised on: 07 May 2019.
Accepted on: 10 June 2019.

___________________HIV Research & Clinical Practice

doxazosin 发表于 2025-3-26 17:01:57

http://reply.papertrans.cn/2/115/11451/11451-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊HIV Research & Clinical Practice 2024/2025影响因子:1.742 (HIV RES CLIN PRACT) (2578-7489). (PHARMACOLOGY & PHARMACY)(